Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $10.1300 (1.71%) ($9.6450 - $10.2600) on Tue. Feb. 14, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.51% (three month average) | RSI | 63 | Latest Price | $10.1300(1.71%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -2.2% a day on average for past five trading days. | Weekly Trend | EDIT advances 2.3% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) XBI(69%) IBB(56%) IWC(51%) IWM(47%) IWO(47%) | Factors Impacting EDIT price | EDIT will decline at least -2.255% in a week (0% probabilities). VIXM(-15%) SMH(-10%) IGOV(-10%) UUP(-6%) TBT(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.255% (StdDev 4.51%) | Hourly BBV | 0 () | Intraday Trend | 2.1% | | | |
|
5 Day Moving Average | $10.02(1.1%) | 10 Day Moving Average | $10.54(-3.89%) | 20 Day Moving Average | $9.73(4.11%) | To recent high | -22.3% | To recent low | 29.7% | Market Cap | $629m | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |